Drug Profile
Varicella zoster virus vaccine - Sinovac (Dalian) Vaccine Technology
Alternative Names: Live attenuated varicella vaccine - Sinovac Biotech/Dalian Vaccine Technology; Varicella vaccine, live - Sinovac (Dalian) Vaccine Technology; Varicella zoster vaccine - Sinovac Biotech/Dalian Vaccine TechnologyLatest Information Update: 20 Mar 2024
Price :
$50
*
At a glance
- Originator GlaxoSmithKline; Sinovac (Dalian) Vaccine Technology
- Developer Sinovac (Dalian) Vaccine Technology
- Class Attenuated vaccines; Varicella vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Varicella zoster virus infections
Most Recent Events
- 01 Mar 2024 Phase-III clinical trials in Varicella zoster virus infections (Prevention, In infants) in Philippines (SC) (NCT06314724)
- 15 Aug 2023 Registered for Varicella zoster virus infections (Prevention) in Kenya, Lebanon (IM), prior to August 2023
- 03 Feb 2023 Efficacy data from a phase III trial of varicella zoster virus vaccine released by Sinovac Biotech